ApprovalTrail

Approval · Notice of Compliance 9268 · 2007

CO FENTANYL: Notice of Compliance 9268

Issued December 31, 2007

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
9268
Date
December 31, 2007
Company
Cobalt Pharmaceuticals IncorporatedToronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Therapeutic class
Opioid analgesic
Canadian reference product
DURAGESIC (Janssen-Ortho Inc.)

Products in this notice

BrandDINStatus today
CO FENTANYL02304120Cancelled Pre Market
CO FENTANYL02304139Cancelled Pre Market
CO FENTANYL02304147Cancelled Pre Market
CO FENTANYL02304155Cancelled Pre Market

Medicinal ingredients